Page 11 of 19 · 454 questions tagged vendor-vetting.
This is my second independent submission on material from the same supplier. This is presented as though it settles something, and I am not convinced it does. I have…
Conditions: CPC · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
Setup, so nobody has to ask: cagrilintide · lot-specific certificate. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not…
Conditions: list of related substances · SSA. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: BCH · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources…
What I have: SWB · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date, and…
The specifics, since they change the answer: GL Biochem · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I…
The specifics, since they change the answer: 96.8% · survodutide · WWB. I am at the decision point and I would rather think it through than improvise. I would rather…
Setup, so nobody has to ask: SGN · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
I sent a payment against an invoice. A block explorer shows it confirmed with plenty of confirmations, correct amount, correct destination. The order status has said…
For reference: 99.1% · survodutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Concretely: QSC · Xi’an Mokemei Biotechnology. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Details up front: QST · Guangzhou JEEP Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
I have kept every message, invoice and document, which I gather is the useful habit. I have read the obvious sources and they disagree with each other, so I would…
What I am working with: FGP · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing each…
Concretely: QYB · ecnoglutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed, which is…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
What I am working with: 98.4% · a GLP-1 receptor agonist · CPC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Setup, so nobody has to ask: chromatogram · GL Biochem. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
What I have: CPC · liraglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
Details up front: CPC · Shanghai Wibson Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The case in front of me: HJ · liraglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several…
Conditions: QSC · Nantong Guangyuan Chemical. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
The particulars: QST · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can anyone…